Page last updated: 2024-08-24

prostratin and Osteoporosis

prostratin has been researched along with Osteoporosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, D; Chen, P; Chu, F; He, Q; Li, Y; Sun, P; Wang, H; Wang, Q; Xu, J; Yang, J; Zhang, G; Zhang, M	1

Other Studies

1 other study(ies) available for prostratin and Osteoporosis

Article	Year
12-Deoxyphorbol 13-acetate inhibits RANKL-induced osteoclastogenesis via the attenuation of MAPK signaling and NFATc1 activation. International immunopharmacology, 2021, Volume: 101, Issue:Pt A Topics: Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; MAP Kinase Signaling System; Mice; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Osteoporosis; Phorbol Esters; RAW 264.7 Cells	2021

Article

Year

12-Deoxyphorbol 13-acetate inhibits RANKL-induced osteoclastogenesis via the attenuation of MAPK signaling and NFATc1 activation.

International immunopharmacology, 2021, Volume: 101, Issue:Pt A

Topics: Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; MAP Kinase Signaling System; Mice; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Osteoporosis; Phorbol Esters; RAW 264.7 Cells

2021